This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Northrop Grumman's Amy Caro Says Genomic Data Will Significantly Advance Healthcare But Security Is Key

Stocks in this article: NOC

WASHINGTON, Nov. 8, 2013 /PRNewswire/ -- Speaking at the U.S. News & World Report Hospital of Tomorrow forum Tuesday, Northrop Grumman Corporation's (NYSE: NOC) Amy Caro, vice president of health IT programs, said advances in genomics and more widespread use of molecular data will enhance healthcare and improve health outcomes but ensuring the security of personal data is key to its accelerated use.


Genomics is the field of study based on identifying and analyzing a person's complete set of DNA and it is beginning to help the medical community predict, diagnose and treat various conditions, although complete genome-sequencing is not yet widely used.

Caro said genomics and proteomics, which is the study of proteins, their structures and functions, will "usher in a new era of personalized medicine, resulting in more accurate diagnoses and targeted treatments that work more effectively." She also said it could lower costs through increasing preventative care, eliminating unnecessary treatment and reducing negative outcomes such as adverse drug reactions.

As an IT systems integrator, Northrop Grumman will be serving as a "value-added facilitator" between the producers and users of this information. The company's role, Caro said, extends beyond IT integration to "incorporate increasing levels of scientific expertise to analyze and visualize data, manage data and ensure the secure exchange of information."

Northrop Grumman is currently developing a number of genomic and proteomic projects in partnership with universities and other companies, utilizing its IT expertise to enable genetic information to be integrated, analyzed and visualized for clinical purposes across healthcare systems.

"Northrop Grumman's focus on the role of information systems will accelerate the translation of genomic findings to clinical care, with the ultimate goal of helping this nation increase healthcare efficiency, reduce healthcare costs and improve health outcomes for its citizens," Caro said.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs